A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)

NCT05072080 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3258

Enrollment

INDUSTRY

Sponsor class

Conditions

Chikungunya Virus

Interventions

BIOLOGICAL: CHIKV VLP/adjuvant
BIOLOGICAL: Placebo

Sponsor

Bavarian Nordic

Collaborators

[object Object]